A pilot study: Metabolic profiling of plasma and saliva samples from newly diagnosed glioblastoma patients

被引:9
|
作者
Bark, Juliana Muller [1 ,2 ,3 ]
Karpe, Avinash V. [4 ,5 ]
Doecke, James D. [6 ]
Leo, Paul [3 ,7 ]
Jeffree, Rosalind L. [8 ,9 ,10 ,11 ]
Chua, Benjamin [9 ,12 ]
Day, Bryan W. [3 ,9 ,11 ]
Beale, David J. [4 ]
Punyadeera, Chamindie [2 ,13 ,14 ,15 ]
机构
[1] Queensland Univ Technol, Fac Hlth, Ctr Biomed Technol, Sch Biomed Sci, Brisbane, Qld, Australia
[2] Griffith Univ, Griffith Inst Drug Discovery, Saliva & Liquid Biopsy Translat Lab, Brisbane, Qld, Australia
[3] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Gardens Point, Qld, Australia
[4] Environm Commonwealth Sci & Ind Res Org CSIRO, Ecosci Precinct, Dutton Pk, Qld, Australia
[5] Commonwealth Sci & Ind Res Org CSIRO, Agr & Food, Acton, ACT, Australia
[6] Royal Brisbane & Womens Hosp, Australian EHlth Res Ctr, Surg Treatment & Rehabil Serv STARS, CSIRO, Level 7, Herston, Qld, Australia
[7] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Translat Genom Grp, Woolloongabba, Australia
[8] QIMR Berghofer Med Res Inst, Herston, Qld, Australia
[9] Univ Queensland, Fac Med, Herston, Qld, Australia
[10] Royal Brisbane & Womens Hosp, Kenneth G Jamieson Dept Neurosurg, Brisbane, Qld, Australia
[11] QIMR Berghofer MRI, Cell & Mol Biol Dept, Sid Faithfull Brain Canc Lab, Brisbane, Qld, Australia
[12] Royal Brisbane & Womens Hosp, Canc Care Serv, Brisbane, Qld, Australia
[13] Griffith Univ, Menzies Hlth Inst, Southport, Qld, Australia
[14] Translat Res Inst, Woolloongabba, Qld, Australia
[15] Griffith Inst Drug Discovery, Saliva & Liquid Biopsy Translat Lab, 46 Don Young Rd, Nathan, Qld 4111, Australia
来源
CANCER MEDICINE | 2023年 / 12卷 / 10期
基金
英国医学研究理事会;
关键词
blood; glioblastoma; lipids; metabolites; metabolomics; saliva; ARGININE DEPRIVATION; CANCER; BIOSYNTHESIS; GLYCOLYSIS; CHALLENGES; BIOMARKERS; PROTEIN; GROWTH; TUMORS; CELLS;
D O I
10.1002/cam4.5857
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Despite aggressive treatment, more than 90% of glioblastoma (GBM) patients experience recurrences. GBM response to therapy is currently assessed by imaging techniques and tissue biopsy. However, difficulties with these methods may cause misinterpretation of treatment outcomes. Currently, no validated therapy response biomarkers are available for monitoring GBM progression. Metabolomics holds potential as a complementary tool to improve the interpretation of therapy responses to help in clinical interventions for GBM patients.Methods: Saliva and blood from GBM patients were collected pre and postoperatively. Patients were stratified conforming their progression-free survival (PFS) into favourable or unfavourable clinical outcomes (>9 months or PFS <= 9 months, respectively). Analysis of saliva (whole-mouth and oral rinse) and plasma samples was conducted utilising LC-QqQ-MS and LC-QTOF-MS to determine the metabolomic and lipidomic profiles. The data were investigated using univariate and multivariate statistical analyses and graphical LASSO-based graphic network analyses.Results: Altogether, 151 metabolites and 197 lipids were detected within all saliva and plasma samples. Among the patients with unfavourable outcomes, metabolites such as cyclic-AMP, 3-hydroxy-kynurenine, dihydroorotate, UDP and cis-aconitate were elevated, compared to patients with favourable outcomes during pre-and post-surgery. These metabolites showed to impact the pentose phosphate and Warburg effect pathways. The lipid profile of patients who experienced unfavourable outcomes revealed a higher heterogeneity in the abundance of lipids and fewer associations between markers in contrast to the favourable outcome group.Conclusion: Our findings indicate that changes in salivary and plasma metabolites in GBM patients can potentially be employed as less invasive prognostic biomarkers/biomarker panel but validation with larger cohorts is required.
引用
收藏
页码:11427 / 11437
页数:11
相关论文
共 50 条
  • [1] A PILOT SAFETY STUDY OF LENALIDOMIDE AND RADIOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Drappatz, Jan
    Wong, Eric T.
    Schiff, David
    Kesari, Santosh
    Batchelor, Tracy T.
    Doherty, Lisa
    LaFrankie, Debra Conrad
    Ramakrishna, Naren
    Weiss, Stephanie
    Smith, Sharon T.
    Ciampa, Abigail
    Zimmerman, Jennifer
    Ostrowsky, Louis
    David, Karly
    Norden, Andrew
    Barron, Loretta
    Sceppa, Christine
    Black, Peter M.
    Wen, Patrick Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (01): : 222 - 227
  • [2] Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma
    Kim, Woo Jin
    Dho, Yun-Sik
    Ock, Chan-Young
    Kim, Jin Wook
    Choi, Seung Hong
    Lee, Soon-Tae
    Kim, Il Han
    Kim, Tae Min
    Park, Chul-Kee
    JOURNAL OF NEURO-ONCOLOGY, 2019, 143 (02) : 321 - 328
  • [3] Proteomic Profiling of Pre- and Post-Surgery Saliva of Glioblastoma Patients: A Pilot Investigation
    Muntiu, Alexandra
    Moresi, Fabiana
    Vincenzoni, Federica
    Rossetti, Diana Valeria
    Iavarone, Federica
    Messana, Irene
    Castagnola, Massimo
    La Rocca, Giuseppe
    Mazzucchi, Edoardo
    Olivi, Alessandro
    Urbani, Andrea
    Sabatino, Giovanni
    Desiderio, Claudia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [4] Oral squamous cell carcinoma diagnosed from saliva metabolic profiling
    Song, Xiaowei
    Yang, Xihu
    Narayanan, Rahul
    Shankar, Vishnu
    Ethiraj, Sathiyaraj
    Wang, Xiang
    Duan, Ning
    Ni, Yan-Hong
    Hu, Qingang
    Zare, Richard N.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (28) : 16167 - 16173
  • [5] Metabolic profiling of follicular fluid and plasma from natural cycle in vitro fertilization patients-a pilot study
    McRae, Cassey
    Baskind, N. Ellissa
    Orsi, Nicolas M.
    Sharma, Vinay
    Fisher, Julie
    FERTILITY AND STERILITY, 2012, 98 (06) : 1449 - +
  • [6] Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma
    Ryu, Samuel
    Ye, Xiaobu
    Olson, Jeffrey J.
    Mikkelsen, Tom
    Bangiyev, Lev
    Lesser, Glenn J.
    Batchelor, Tracy
    Nabors, Burt
    Desideri, Serena
    Walbert, Tobias
    Grossman, Stuart A.
    NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
  • [7] Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis
    Seliger, Corinna
    Genbrugge, Els
    Gorlia, Thierry
    Chinot, Olivier
    Stupp, Roger
    Nabors, Burt
    Weller, Michael
    Hau, Peter
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (03) : 803 - 809
  • [8] Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility - a prospective, translational study
    Noroxe, Dorte S.
    Yde, Christina W.
    Ostrup, Olga
    Michaelsen, Signe R.
    Schmidt, Ane Y.
    Kinalis, Savvas
    Torp, Mathias H.
    Skjoth-Rasmussen, Jane
    Brennum, Jannick
    Hamerlik, Petra
    Poulsen, Hans S.
    Nielsen, Finn C.
    Lassen, Ulrik
    MOLECULAR ONCOLOGY, 2020, 14 (11) : 2727 - 2743
  • [9] Newly Diagnosed Glioblastoma in Elderly Patients
    Carlen A. Yuen
    Marissa Barbaro
    Aya Haggiagi
    Current Oncology Reports, 2022, 24 : 325 - 334
  • [10] Boron neutron capture therapy for newly diagnosed glioblastoma: A pilot study in Tsukuba
    Yamamoto, T.
    Nakai, K.
    Tsurubuchi, T.
    Matsuda, M.
    Shirakawa, M.
    Zaboronok, A.
    Endo, K.
    Matsumura, A.
    APPLIED RADIATION AND ISOTOPES, 2009, 67 (7-8) : S25 - S26